SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000944809-20-000041
Filing Date
2020-11-19
Accepted
2020-11-19 16:01:49
Documents
1
Group Members
FROST GAMMA INVESTMENTS TRUSTPHILLIP FROST, M.D.STEVEN D. RUBIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A cocrystalsc13-da11x13x20.htm SC 13D/A 147316
  Complete submission text file 0000944809-20-000041.txt   149412
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filed by) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Subject) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87608 | Film No.: 201328819
SIC: 2834 Pharmaceutical Preparations